Published in Front Neuroanat on October 27, 2010
Transgenic mouse lines subdivide external segment of the globus pallidus (GPe) neurons and reveal distinct GPe output pathways. J Neurosci (2014) 1.02
Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects. Eur J Neurosci (2012) 0.97
Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality? Neurotherapeutics (2016) 0.96
Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med (2012) 0.94
The corticostriatal and corticosubthalamic pathways: two entries, one target. So what? Front Syst Neurosci (2011) 0.92
Loss of specificity in Basal Ganglia related movement disorders. Front Syst Neurosci (2011) 0.83
Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques. Front Neuroanat (2014) 0.83
Review: electrophysiology of basal ganglia and cortex in models of Parkinson disease. J Parkinsons Dis (2013) 0.82
Neural circuit modulation during deep brain stimulation at the subthalamic nucleus for Parkinson's disease: what have we learned from neuroimaging studies? Brain Connect (2013) 0.82
Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys. J Neurophysiol (2011) 0.81
Dynamical changes in neurological diseases and anesthesia. Curr Opin Neurobiol (2012) 0.81
Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs. Neurobiol Dis (2012) 0.80
Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF. PLoS One (2011) 0.79
The neurobiological link between OCD and ADHD. Atten Defic Hyperact Disord (2014) 0.79
Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. Front Aging Neurosci (2014) 0.79
Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys. J Neurophysiol (2014) 0.78
Subthalamic, not striatal, activity correlates with basal ganglia downstream activity in normal and parkinsonian monkeys. Elife (2016) 0.77
Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons. PLoS One (2015) 0.76
Morphological changes of glutamatergic synapses in animal models of Parkinson's disease. Front Neuroanat (2015) 0.76
Reduced cortical innervation of the subthalamic nucleus in MPTP-treated parkinsonian monkeys. Brain (2015) 0.76
Morphological evidence for dopamine interactions with pallidal neurons in primates. Front Neuroanat (2015) 0.75
Dopamine D1 Receptor Immunoreactivity on Fine Processes of GFAP-Positive Astrocytes in the Substantia Nigra Pars Reticulata of Adult Mouse. Front Neuroanat (2017) 0.75
Basal Ganglia Circuits: What's Now and Next? Front Neuroanat (2012) 0.75
Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease. Proc Natl Acad Sci U S A (2016) 0.75
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
Dopamine receptors: from structure to function. Physiol Rev (1998) 8.90
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (1990) 8.07
The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol (1996) 7.24
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res (1990) 5.79
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol (2006) 5.49
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev (1995) 5.23
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
Behavioral dopamine signals. Trends Neurosci (2007) 4.79
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med (2003) 4.51
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature (2007) 4.36
Temporally precise in vivo control of intracellular signalling. Nature (2009) 4.14
Striatal plasticity and basal ganglia circuit function. Neuron (2008) 3.89
Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci (2007) 3.64
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron (2006) 3.58
The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol (1994) 3.42
Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci Res (2002) 3.34
BAC to the future: the use of bac transgenic mice for neuroscience research. Nat Rev Neurosci (2001) 3.32
Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev (1995) 3.32
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci (2003) 3.25
Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci (2002) 2.75
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology (2003) 2.65
Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol (1987) 2.65
The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci (1995) 2.54
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg (2005) 2.53
Dopamine receptor activation is required for corticostriatal spike-timing-dependent plasticity. J Neurosci (2008) 2.46
Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg (2002) 2.45
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol (1978) 2.29
Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci (2000) 2.22
Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol (1998) 2.21
Activity of pallidal neurons during movement. J Neurophysiol (1971) 2.15
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A (1993) 2.10
Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol (2000) 2.03
Basal-ganglia 'projections' to the prefrontal cortex of the primate. Cereb Cortex (2002) 1.98
Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology (1999) 1.94
Neural mechanisms of reward-related motor learning. Curr Opin Neurobiol (2003) 1.90
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci (1995) 1.90
The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci (1995) 1.89
Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. J Neurosci (1999) 1.80
Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci (1986) 1.76
Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev (2008) 1.75
Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons. Neuron (1995) 1.75
Pathophysiology of parkinsonism. Clin Neurophysiol (2008) 1.71
Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature (1996) 1.71
The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci (1996) 1.70
D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse (1987) 1.69
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience (1995) 1.68
Multiple output channels in the basal ganglia. Science (1993) 1.68
Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res (1991) 1.67
Biochemical aspects of Parkinson's disease. Neurology (1998) 1.67
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A (2007) 1.66
Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci (1995) 1.61
Macro-architecture of basal ganglia loops with the cerebral cortex: use of rabies virus to reveal multisynaptic circuits. Prog Brain Res (2004) 1.58
Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci (2001) 1.57
Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci (1996) 1.56
Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol (1999) 1.55
Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque. J Neurophysiol (2005) 1.51
Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science (1994) 1.50
Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol (2000) 1.44
Dopaminergic innervation of the human striatum in Parkinson's disease. Mov Disord (2005) 1.44
The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states. Brain Res Bull (2008) 1.43
Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci (1997) 1.41
Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol (2000) 1.40
Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J Comp Neurol (1987) 1.39
Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res (1975) 1.39
The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol (1990) 1.39
Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci U S A (1991) 1.38
FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat Neurosci (2008) 1.36
Subthalamic nucleus lesions increase impulsive action and decrease impulsive choice - mediation by enhanced incentive motivation? Eur J Neurosci (2006) 1.36
Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J Neurosci (2003) 1.34
Control of extracellular dopamine at dendrite and axon terminals. J Neurosci (2010) 1.33
Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci U S A (1994) 1.33
Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov Disord (2008) 1.31
Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience (1997) 1.31
Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci (2000) 1.31
Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse (2000) 1.31
Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol (2000) 1.31
Anatomy of the dopamine system in the basal ganglia. Trends Neurosci (2000) 1.30
Electrophysiology of globus pallidus neurons in vitro. J Neurophysiol (1994) 1.29
The primate substantia nigra and VTA: integrative circuitry and function. Crit Rev Neurobiol (1997) 1.28
The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience (1996) 1.28
Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst Rev (2008) 1.28
D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci (1986) 1.27
D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. J Chem Neuroanat (2001) 1.26
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia. J Neurochem (2006) 1.26
Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol (1998) 1.26
Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat (2006) 1.25
Dopamine D5 receptors of rat and human brain. Neuroscience (2000) 1.25
Organization of inputs from cingulate motor areas to basal ganglia in macaque monkey. Eur J Neurosci (2001) 1.24
Enhancement of excitatory synaptic integration by GABAergic inhibition in the subthalamic nucleus. J Neurosci (2005) 1.24
High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem (1994) 1.23
The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards. Nat Neurosci (2005) 1.21
Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J Neurophysiol (2001) 1.20
Stereotypic and anticataleptic activities of amphetamine after intracerebral injections. Eur J Pharmacol (1972) 1.19
Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci (1998) 1.17
The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord (2008) 1.17
Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. Neuropharmacology (2001) 1.17
A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience (1987) 1.16
Circuits and circuit disorders of the basal ganglia. Arch Neurol (2007) 3.97
Pathophysiology of parkinsonism. Clin Neurophysiol (2008) 1.71
Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord (2006) 1.71
Localization and pharmacological modulation of GABA-B receptors in the globus pallidus of parkinsonian monkeys. Exp Neurol (2011) 1.66
(18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism. Exp Neurol (2010) 1.61
Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain (2011) 1.55
Role of external pallidal segment in primate parkinsonism: comparison of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism and lesions of the external pallidal segment. J Neurosci (2004) 1.48
The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states. Brain Res Bull (2008) 1.43
Update on models of basal ganglia function and dysfunction. Parkinsonism Relat Disord (2009) 1.30
Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology (2011) 1.21
Interactions between cortical rhythms and spiking activity of single basal ganglia neurons in the normal and parkinsonian state. Cereb Cortex (2008) 1.04
Effects of striatal GABA A-receptor blockade on striatal and cortical activity in monkeys. J Neurophysiol (2008) 1.03
Nonlinear analysis of discharge patterns in monkey basal ganglia. Brain Res (2006) 1.02
GABAergic circuits in the basal ganglia and movement disorders. Prog Brain Res (2007) 1.02
Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys. J Neurophysiol (2007) 1.02
Deep brain stimulation for movement and other neurologic disorders. Ann N Y Acad Sci (2012) 1.01
A method to record changes in local neuronal discharge in response to infusion of small drug quantities in awake monkeys. J Neurosci Methods (2004) 0.98
Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects. Eur J Neurosci (2012) 0.97
Effects of transient focal inactivation of the basal ganglia in parkinsonian primates. J Neurosci (2002) 0.95
GABAergic modulation of the activity of globus pallidus neurons in primates: in vivo analysis of the functions of GABA receptors and GABA transporters. J Neurophysiol (2005) 0.94
Effects of stimulation of the centromedian nucleus of the thalamus on the activity of striatal cells in awake rhesus monkeys. Eur J Neurosci (2009) 0.93
In vivo optogenetic control of striatal and thalamic neurons in non-human primates. PLoS One (2012) 0.92
GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen. J Comp Neurol (2013) 0.91
Ultrastructural localization and function of dopamine D1-like receptors in the substantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys. Eur J Neurosci (2010) 0.91
Changing views of basal ganglia circuits and circuit disorders. Clin EEG Neurosci (2010) 0.91
Localization and function of GABA transporters in the globus pallidus of parkinsonian monkeys. Exp Neurol (2010) 0.89
A non-invasive technique to monitor wakefulness during electrophysiologic recording experiments in primates. J Neurosci Methods (2008) 0.88
Cortical potentials evoked by deep brain stimulation in the subthalamic area. Front Syst Neurosci (2011) 0.88
Parkinsonism-related features of neuronal discharge in primates. J Neurophysiol (2013) 0.88
Neuronal activity in the subthalamic nucleus modulates the release of dopamine in the monkey striatum. Eur J Neurosci (2008) 0.87
Selection of optimal programming contacts based on local field potential recordings from subthalamic nucleus in patients with Parkinson's disease. Neurosurgery (2010) 0.86
Making the lifetime connection between brain and machine for restoring and enhancing function. Prog Brain Res (2011) 0.86
Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex. Neuropharmacology (2012) 0.86
Localization and Function of GABA Transporters GAT-1 and GAT-3 in the Basal Ganglia. Front Syst Neurosci (2011) 0.84
Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys. Adv Behav Biol (2009) 0.81
Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys. J Neurophysiol (2011) 0.81
The cortico-pallidal projection: an additional route for cortical regulation of the basal ganglia circuitry. Mov Disord (2014) 0.81
A new probe to monitor the effects of drugs on local field potentials. J Neurosci Methods (2006) 0.80
Clinical subtypes of anterocollis in parkinsonian syndromes. J Neurol Sci (2011) 0.80
More than meets the eye-myelinated axons crowd the subthalamic nucleus. Mov Disord (2013) 0.78
Continuous monitoring of intracerebral glutamate levels in awake monkeys using microdialysis and enzyme fluorometric detection. J Neurosci Methods (2003) 0.78
Longitudinal wearable tremor measurement system with activity recognition algorithms for upper limb tremor. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75
Quantitative assessment of arm tremor in people with neurological disorders. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75
Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys. ACS Chem Neurosci (2016) 0.75